What is the typical fecal calprotectin level in acute bacterial gastroenteritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fecal Calprotectin Levels in Bacterial Gastroenteritis

In acute bacterial gastroenteritis, fecal calprotectin levels are typically markedly elevated, ranging from approximately 700-1000 μg/g (or mg/kg), which is substantially higher than the levels seen in viral gastroenteritis (approximately 90-100 μg/g).

Specific Values from Clinical Studies

The most robust pediatric data shows:

  • Bacterial pathogens: Median fecal calprotectin of 985 μg/g (IQR 272-1984 μg/g) 1
  • Viral pathogens: Median of 560 μg/g (IQR 60-669 μg/g), with this difference being statistically significant (P = 0.019) 1

Another well-designed study found even more pronounced differences:

  • Bacterial gastroenteritis: Median 1870 μg/g (IQR 822.5-2100 mg/L)
  • Viral gastroenteritis: Median 95 μg/g (IQR 21.3-240.9 mg/L) 2

Pathogen-Specific Patterns

When broken down by specific bacterial pathogens, the levels are consistently elevated 3:

  • Salmonella infection: Median 765 μg/g (range 252-1246 μg/g)
  • Campylobacter infection: Median 689 μg/g (range 307-1046 μg/g)
  • Clostridium difficile: Median 739 μg/g in one cohort 4

In contrast, viral infections show much lower levels:

  • Rotavirus: Median 89 μg/g (range 11-426 μg/g)
  • Norovirus: Median 93 μg/g (range 25-405 μg/g)
  • Adenovirus: Median 95 μg/g (range 65-224 μg/g) 3

Diagnostic Cutoff Values

For distinguishing bacterial from viral gastroenteritis, an optimal cutoff of 710-815 μg/g provides the best diagnostic performance:

  • At 710 mg/L cutoff: Sensitivity 88.9%, specificity 76.0% 2
  • At 815 μg/g cutoff: Area under ROC curve of 0.739 1
  • When combined with stool hemoglobin (cutoff 158 ng/mL), diagnostic accuracy improves to AUC 0.870 1

Clinical Correlation with Disease Severity

Fecal calprotectin levels correlate directly with clinical severity in bacterial gastroenteritis 3:

  • Severe disease activity: Median 843 μg/g (range 284-1246 μg/g)
  • Moderate disease activity: Median 402 μg/g (range 71-995 μg/g)
  • Mild disease activity: Median 87 μg/g (range 11-438 μg/g)

Important Clinical Caveats

Age-related considerations: In healthy infants under 12 months, fecal calprotectin can be very high physiologically and decreases significantly over the first year of life 5. This must be factored into interpretation in young infants.

Non-specificity: While bacterial gastroenteritis causes marked elevation, remember that fecal calprotectin is a marker of intestinal inflammation, not bacterial infection per se. Other inflammatory conditions (IBD, colorectal cancer) also elevate levels 6. The clinical context—acute diarrheal illness with appropriate symptoms—is essential for proper interpretation.

Adult data: In adults with acute infectious diarrhea, patients with positive stool PCR for bacterial pathogens showed significantly elevated calprotectin (1124.5 ± 816.9 mg/kg) compared to PCR-negative patients (609 ± 713.2 mg/kg, P = 0.001) 7.

Practical Application

When evaluating acute gastroenteritis:

  • Fecal calprotectin >700-800 μg/g strongly suggests bacterial etiology
  • Fecal calprotectin <100-200 μg/g suggests viral etiology
  • Intermediate values (200-700 μg/g) require clinical correlation and may benefit from additional testing like stool hemoglobin or direct pathogen detection

The combination of elevated fecal calprotectin with positive stool microscopy (presence of fecal leukocytes) further increases diagnostic certainty for bacterial gastroenteritis 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.